Bradlee Johnson, MD
Urology · Lancaster, SCNPI 1629304068
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 13 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Medtronic at 32.6% of the total. Reporting peaked in 2020 at $62 and has fallen 53.0% since, to $29 in 2025. That places this record below the midpoint for urology clinicians in SC, where the typical reported total is $3,399.
Across 13 payments — averaging $19.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$82
- Peerless Surgical Inc.$48
- Calyxo, Inc.$42
- AbbVie$29
- Boston Scientific$24
- Innovation Technologies Inc$15
- plus $12 from 1 others
What the payments were for
- Food & beverage$252100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 6 | $82 |
| Peerless Surgical Inc. | 1 | $48 |
| Calyxo, Inc. | 1 | $42 |
| AbbVie | 2 | $29 |
| Boston Scientific | 1 | $24 |
| Innovation Technologies Inc | 1 | $15 |
| Endo Pharmaceuticals Inc. | 1 | $12 |
How this compares
$252 in reported general payments places this provider in the 10th percentile of 196 urology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 100 | $56,114 |
| Tamsulosin Hcl | 880 | $10,522 |
| Mirabegron ErMirabegron | 22 | $7,835 |
| Oxybutynin Chloride ErOxybutynin Chloride | 429 | $5,666 |
| Finasteride | 175 | $3,061 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 123 | $2,766 |
| Testosterone | 28 | $2,708 |
| Solifenacin Succinate | 21 | $1,664 |
| Testosterone Cypionate | 88 | $1,573 |
| Potassium Citrate ErPotassium Citrate | 22 | $1,088 |
| Methenamine Hippurate | 12 | $813 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 214 | $734 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 17 | $731 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 112 | $696 |
| Cefdinir | 23 | $581 |
Paid to pharmacies, not to this prescriber.
Other urology in Lancaster
- Neal ShoreMyrtle Beach$3.2M
- Manish PatelElgin$213K
- Sandip PrasadCharleston$177K
- Benjamin DropkinGreenville$65K
- Ian MarshallCharleston$60K
- Elizabeth BozemanFlorence$57K
- Thomas KeaneCharleston$52K
- Abhishek SrivastavaMyrtle Beach$41K
- William BogacheMyrtle Beach$41K
- Christopher BallantyneGreenville$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.